Overview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic pr...Hiroshima University
The research group at the Department of Clinical and Molecular Genetics, Hiroshima University Hospital...Hiroshima University
BRCA2:c.67G>C is associated with aberrant splicing and an exceptional response to platinum-based chemotherapy...Hiroshima University
Cohort 4 of the Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP), which took place in the summer of 2025...The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards)
AstraZeneca - What Science Can DoThe Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards)
